Agilent and Samsung Collaborate

Agilent (Santa Clara, California, USA) will collaborate with the Samsung Medical Centre, one of South Korea's leading medical institutes, on medicine and genetics research projects.

The department of laboratory medicine and genetics research, which is part of the centre, will use Agilent's bio-analytical instruments to analyse clinical samples and develop novel clinical assays.

Professor Sung-Hwa Hong, executive vice president, research and development, Samsung Medical Centre, said: “Based on our memoradum of understanding, projects such as the discovery and validation of protein biomarkers for applications in clinical trials, the development of methodology for applications involving hormones and vitamins, and assay development for a tumour marker for certain cancers and diseases will be undertaken at Samsung Medical Centre in cooperation with Agilent.”

Rod Minett, general manager of Agilent's life sciences business in South Korea and the South Asia Pacific commented: “For the detailed and rigorous tests required for these research projects, Agilent will provide our bio-analytical instruments, on-site and remote application and technical support, as well as our research experts to work closely with professor Hong's team. We look forward to close collaboration with Samsung Medical Centre to accelerate the advancement of science and medical developments, and ultimately to improve the quality of life for mankind.”

For more information please visit ref="http://www.agilent.com">www.agilent.com